The global medical devices outsourcing market expected to grow at compound annual growth rate (CAGR) of 10.6% during the forecast period from 2025 to 2033. Outsourcing of medical devices manufacturing has become a pervasive aspect of medical device industry with every company are choosing outsourcing over in-house manufacturing. This has led the companies to focus on their core competencies and new product development. The trend of outsourcing medical devices R&D is also increasing. Outsourcing has become the favorite option for the companies as it reduces costs, accelerate market entry of products and curtails business risks.
The global incinerators market growing at CAGR of 4.22% across the forecast period from 2025 to 2033. Rate of waste generation is rising with tremendous pace across the world credited to rapidly growing population along with urbanization trend. In 2020, the solid waste generation across urban areas in the world accounted for 2.01 Bn Tonnes. With such rapid rate, annual waste generation expected to hit the count of 3.40 Bn Tonnes in 2050. Furthermore, rising advancements in technology expected to enhance the performance and provide lucrative opportunities to incinerator manufacturers across the world.
The global disposable medical supplies market held US$ 112.6 Bn in 2017 and expected to grow at compound annual growth rate (CAGR) of 6.2% during the forecast period from 2018 to 2026. The market is largely driven by growing hospitalization and volume of surgeries performed, growing chronic diseases and stringent infection prevention control strategies around the world.
The smart inhalers market is set to reach from US$ 1,006.6 Mn in 2017 to US$ 3,674.6 Mn by 2026 at a compound annual growth rate (CAGR) of 15.7% during the forecast period from 2018 to 2026. Smart inhalers are mounted on respiratory inhalers and nebulizers and provides its services via wireless smart apps and cloud computing systems. They are useful in adjusting the inhaled dose and also reminds the patients regularly by sending alert messages to take medication on time, thereby optimally enhancing patient adherence and compliance with inhaled medications prescribed for chronic respiratory diseases such as COPD and asthma.
Flea and ticks are parasites that cause discomfort and illness in pets which can affect humans too. Fleas and ticks can be easily controlled by usage of safe and effective products or by keeping animals far off places where flea and ticks thrive. Tick bites are irritating and painful while the variety of diseases they transmit are anaplasmosis, babesiosis ehrlichiosis etc. Ticks prefer moist, dark and bushy areas to lay eggs.
Respiratory inhalers are used to administer an extensive range of medications such as beta-agonists, anticholinergic, corticosteroids and certain antibiotics. Respiratory inhalers are used to provide relief of symptoms in various respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, bronchitis and cystic fibrosis. In such respiratory conditions both mild and severe symptoms occur such as coughing, shortness of breath, chest congestion, respiratory discomfort and even death in extreme cases. Thus it becomes important to relieve the symptoms immediately which is accomplished by the use of inhalers.
The global Purging Compounds market was valued at US$ 450.5 million in 2020. Increasing demand for plastic processing machinery coupled with the benefits offered by the purging compounds such as low material wastage, lower production cost, high efficiency, and reduced machine downtime are a few of the major factors that are expected to fuel the demand for the purging compounds market, globally.
Ocular drug delivery is a cumbersome challenge to the researchers and medical field as the physiology and anatomy of eye is relatively complex. The conventional drugs are available in the market, but they are lesser efficient to act some particular sites of eye. Therefore research for enhanced eye treatment is still an ongoing process to develop advanced technology with better outcome. Topical treatment is the conventional approach and still dominates the market owing to easy application and in terms of affordability.
The global carbon fiber reinforced plastic market was valued at US$ 32.21 billion in 2016. Carbon fiber reinforced plastic market is mainly driven by the increasing demand from developing economies coupled with environmental regulations towards energy efficient & environmentally friendly products.
The report titled “Pulmonary Drug Delivery Devices Market- Growth, Future Prospects, and Competitive Analysis, 2025 – 2033” offers strategic insights into the overall pulmonary drug delivery devices market along with the market size and estimates for the duration 2020 to 2033. The said research study covers in-depth analysis of multiple market segments based on type of technology, application, and different geographies.
The drug delivery market plays a crucial role in the healthcare industry, providing innovative solutions for the delivery of drugs and biologics to patients. Drug delivery technologies enable the targeted delivery of drugs to specific sites in the body, improving the efficacy and safety of treatments while reducing side effects. One of the primary drivers of the drug delivery market is the increasing prevalence of chronic diseases. According to the World Health Organization, chronic diseases such as cancer, diabetes, and cardiovascular disease account for more than 70% of all deaths globally. The rising prevalence of these diseases has led to an increase in demand for new and innovative drug delivery technologies, which has in turn driven the growth of the drug delivery market. The global drug delivery market is expected to grow at a CAGR of 8.5% during the period of 2023 to 2031. The increasing demand for new drug delivery technologies, coupled with the growing prevalence of chronic diseases, is expected to drive the growth of the market in the coming years.
Personalized medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. This approach has the potential to improve patient outcomes and reduce healthcare costs by providing more effective and targeted treatments. The development of personalized medicine requires the use of advanced drug delivery technologies, which has contributed to the growth of the drug delivery market. One of the emerging trends in the drug delivery market is the use of nanotechnology. Nanoparticles can be used to deliver drugs to specific sites in the body, improving the efficacy and safety of treatments. Nanoparticle-based drug delivery systems are being developed for a range of applications, including cancer treatment, gene therapy, and vaccine delivery. Another trend in the drug delivery market is the development of implantable drug delivery devices. Implantable devices can provide sustained drug release over an extended period, reducing the need for frequent injections or oral medication. Implantable drug delivery devices are being developed for a range of applications, including diabetes management, pain management, and hormone replacement therapy.
The increasing focus on patient-centricity is also driving the growth of the drug delivery market. Patient-centric drug delivery technologies involve placing the patient at the center of the drug delivery process, with a focus on improving patient adherence and outcomes. This approach can improve the efficacy and safety of treatments, while also reducing healthcare costs by minimizing hospitalization and emergency room visits. Finally, the growing interest in combination therapies is driving the development of new drug delivery technologies. Combination therapies involve the use of multiple drugs to treat a single condition, improving the efficacy and safety of treatments. Drug delivery technologies that enable the simultaneous delivery of multiple drugs are being developed for a range of applications, including cancer treatment and infectious disease.
The drug delivery market is a critical component of the healthcare industry, providing innovative solutions for the delivery of drugs and biologics to patients. The increasing prevalence of chronic diseases, the growing focus on personalized medicine, and the emerging trends in nanotechnology, implantable devices, patient-centricity, and combination therapies are expected to drive the growth of the drug delivery market. As the demand for new and innovative drug delivery technologies continues to increase, the drug delivery market is expected to remain a critical component of the healthcare industry in the coming years. Companies that provide drug delivery services are well-positioned to capitalize on this growing market.
